Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

NUVB

Nuvation Bio Inc

Dec 12 • 11:27AM ET

2.68

Dollar change +0.00
Percentage change 0.19	%

Healthcare • Biotechnology • USA • NYSE

Peers: GILD AMGN REGN VRTX BIIB MRNA BMY PFE LLY SNY

| Held by: IWM VTI VXF IWN IBB SCHA VTWO DFAC IWC IHE

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.17	Insider Own	32.40%	Shs Outstand	335.25M	Perf Week	-3.07%
Market Cap	906.37M	Forward P/E	-	EPS next Y	-0.58	Insider Trans	0.92%	Shs Float	228.20M	Perf Month	-8.36%
Income	-532.28M	PEG	-	EPS next Q	-0.14	Inst Own	43.31%	Short Float	6.17%	Perf Quarter	-11.97%
Sales	2.16M	P/S	419.61	EPS this Y	-510.95%	Inst Trans	32.62%	Short Ratio	7.10	Perf Half Y	-10.20%
Book/sh	1.50	P/B	1.80	EPS next Y	72.95%	ROA	-88.53%	Short Interest	14.07M	Perf Year	101.88%
Cash/sh	1.63	P/C	1.65	EPS next 5Y	-	ROE	-95.54%	52W Range	1.29 - 4.16	Perf YTD	77.81%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-105.67%	52W High	-35.45%	Beta	1.46
Dividend TTM	-	Quick Ratio	9.57	Sales past 5Y	0.00%	Gross Margin	-56.38%	52W Low	107.34%	ATR (14)	0.16
Dividend Ex-Date	-	Current Ratio	9.57	EPS Y/Y TTM	-473.10%	Oper. Margin	-6218.59%	RSI (14)	47.79	Volatility	5.30% 5.79%
Employees	51	Debt/Eq	0.02	Sales Y/Y TTM	-	Profit Margin	-24619.84%	Recom	1.00	Target Price	6.20
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	-67.71%	Payout	-	Rel Volume	0.37	Prev Close	2.68
Sales Surprise	-	EPS Surprise	-19.05%	Sales Q/Q	-	Earnings	Nov 06 AMC	Avg Volume	1.98M	Price	2.68
SMA20	-3.09%	SMA50	4.98%	SMA200	-5.89%	Trades		Volume	247,185	Change	0.19%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-27-24	Upgrade	Jefferies	Hold → Buy	$1.40 → $10
Mar-26-24	Upgrade	BTIG Research	Neutral → Buy	$5
Jan-06-23	Downgrade	Jefferies	Buy → Hold	$5 → $2
Aug-02-22	Downgrade	BTIG Research	Buy → Neutral
Aug-02-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$8 → $2.50
May-04-22	Initiated	H.C. Wainwright	Buy	$14
Oct-15-21	Resumed	BTIG Research	Buy	$16
Apr-06-21	Initiated	RBC Capital Mkts	Outperform	$15
Mar-08-21	Initiated	Wedbush	Outperform	$20
Mar-08-21	Initiated	Jefferies	Buy	$20
Mar-08-21	Initiated	Cowen	Outperform
Mar-08-21	Initiated	BTIG Research	Buy	$16
Mar-08-21	Initiated	BMO Capital Markets	Outperform	$16

Show Previous Ratings

Nov-26-24 08:00AM	Nuvation Bio to Present at the 7th Annual Evercore ISI HealthCONx Conference (Business Wire)
Nov-12-24 04:05PM	Nuvation Bio to Present at the Jefferies London Healthcare Conference (Business Wire)
Nov-06-24 04:05PM	Nuvation Bio Reports Third Quarter 2024 Financial Results and Provides Business Update (Business Wire) +9.48%
01:11AM	Nuvation Bio Inc. (NUVB): Promising Penny Stock with Strong Oncology Pipeline (Insider Monkey)
Oct-16-24 09:06AM	Is Nuvation Bio Inc. (NUVB) the Hottest Penny Stock to Invest in According to Hedge Funds? (Insider Monkey) +10.30%
11:51AM	Loading…
Oct-14-24 11:51AM	Is Nuvation Bio Inc. (NUVB) Hedge Funds Favorite Penny Stock? (Insider Monkey)
Oct-09-24 08:02AM	Growing Confidence in Nuvation Bio, Inc. (NUVB) as Hedge Fund Holdings Increase to 35 (Insider Monkey)
Oct-07-24 04:05PM	Nuvation Bio Appoints Industry Veteran Philippe Sauvage as Chief Financial Officer (Business Wire) -9.96%
Oct-02-24 02:02AM	Navigating Legal Uncertainty: Nuvation Bio Inc.s Chinese Operations and the Shifting Landscape of Chinas Civil Law System (TipRanks)
Sep-14-24 03:05AM	Positive Pooled Data from Nuvation Bio's TRUST-I and TRUST-II Studies Highlight Taletrectinib's Best-in-Class Potential for Patients with Advanced ROS1-positive NSCLC, Supporting Planned New Drug Application Submission in the Fourth Quarter of 2024 (Business Wire)
Sep-09-24 08:00AM	Nuvation Bio to Present at the Cantor Global Healthcare Conference (Business Wire) +6.45%
Aug-06-24 06:32AM	Nuvation Bio pauses oncology drug after Phase I efficacy and safety analysis (Clinical Trials Arena) -6.29%
Aug-05-24 02:27PM	Small-Cap Cancer-Focused Nuvation Bio Pulls Plug On Early-Stage Program After Considering Phase 1 Solid Tumor Data (Benzinga) -5.36%
08:00AM	Nuvation Bio Reports Second Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Jul-23-24 04:05PM	Nuvation Bio Announces Updates and Upcoming Presentations for its ROS1 Inhibitor, Taletrectinib (Business Wire) +10.06%
01:13AM	Loading…
Jun-02-24 01:13AM	Innovent Announces TaletrectinibROS1 InhibitorUpdated Data from Pivotal Phase 2 TRUST-I Study of are Published in the JCO and Orally Presentedat 2024 ASCO Annual Meeting (PR Newswire)
Jun-01-24 08:10AM	Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual Meeting (Business Wire)
May-29-24 04:05PM	Nuvation Bio to Present at the Jefferies Global Healthcare Conference (Business Wire)
May-14-24 10:54PM	NUVB Stock Earnings: Nuvation Bio Beats EPS for Q1 2024 (InvestorPlace)
05:08PM	Nuvation Bio Q1 Loss Narrows; Shares Fall After Hours (MT Newswires)
04:05PM	Nuvation Bio Reports First Quarter 2024 Financial Results and Provides Business Update (Business Wire)
Apr-24-24 10:01AM	Nuvation Bio to Present Updated Data on Taletrectinib, a ROS1 inhibitor, at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting (Business Wire)
Apr-10-24 04:01PM	Nuvation Bio Completes Acquisition of AnHeart Therapeutics (Business Wire) -5.57%
Mar-28-24 08:00AM	Nuvation Bio Announces Appointment of Colleen Sjogren as Chief Commercial Officer (Business Wire) -8.31%
Mar-25-24 07:00AM	Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (Business Wire)
Mar-14-24 04:05PM	Nuvation Bio Doses First Patient in Phase 1/2 Study of NUV-1511 for the Treatment of Advanced Solid Tumors (Business Wire) -9.13%
08:45AM	Biotech's Role in Addressing the Pancreatic Cancer Emergency (PR Newswire)
Mar-08-24 12:00PM	Nuvation Bio Inc. (NUVB) Is Up 25.28% in One Week: What You Should Know (Zacks)
Feb-29-24 04:01PM	Nuvation Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update (Business Wire) -5.08% +19.25%
Feb-27-24 03:30AM	12 Best Medical Stocks to Buy Under $10 (Insider Monkey)
04:10PM	Loading…
Jan-08-24 04:10PM	Nuvation Bio Announces Appointment of Dr. Robert Mashal to its Board of Directors (Business Wire)
04:05PM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-1511 for the Treatment of Advanced Solid Tumors (Business Wire)
Nov-13-23 04:05PM	Nuvation Bio Announces Departure of Chief Financial Officer (Business Wire) +5.47%
Nov-02-23 06:04PM	Nuvation Bio Inc (NUVB) Reports Q3 2023 Financial Results (GuruFocus.com) +10.34% +5.47%
04:10PM	Nuvation Bio Reports Third Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Aug-03-23 04:10PM	Nuvation Bio Reports Second Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Jul-13-23 09:45AM	15 Best Penny Stocks To Buy Now (Insider Monkey)
Jun-01-23 04:05PM	Nuvation Bio Announces Formation of Oncology-Focused Scientific Advisory Board (Business Wire)
May-16-23 06:23AM	Nuvation Bio Insider Ups Holding During Year \ (Simply Wall St.)
May-04-23 04:05PM	Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update (Business Wire)
Mar-21-23 05:10PM	12 Best Biotech Stocks To Buy Under $20 (Insider Monkey) -5.17%
Mar-18-23 06:48PM	The 7 Worst Stocks to Buy Now (InvestorPlace)
Mar-15-23 04:05PM	Nuvation Bio Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (Business Wire)
Feb-17-23 05:05AM	With 48% stake, Nuvation Bio Inc. (NYSE:NUVB) seems to have captured institutional investors' interest (Simply Wall St.)
Jan-17-23 08:19AM	Companies Like Nuvation Bio (NYSE:NUVB) Are In A Position To Invest In Growth (Simply Wall St.)
Dec-19-22 04:05PM	Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868 (Business Wire) -5.08% +15.48%
Dec-07-22 05:03AM	Trade Alert: The Independent Director Of Nuvation Bio Inc. (NYSE:NUVB), Kathryn Falberg, Has Just Spent US$484k Buying A Few More Shares (Simply Wall St.)
Nov-03-22 04:05PM	Nuvation Bio Reports Third Quarter 2022 Financial Results and Provides Business Update (Business Wire)
Aug-11-22 10:01AM	ProKidney Strengthens Board of Directors with Appointments of Dr. John M. Maraganore and Jennifer Fox (GlobeNewswire)
Aug-10-22 08:45AM	Nuvation Bio (NYSE:NUVB) Is In A Good Position To Deliver On Growth Plans (Simply Wall St.)
Aug-04-22 04:05PM	Nuvation Bio Reports Second Quarter 2022 Financial Results and Provides Business Update (Business Wire) +5.06%
Aug-01-22 04:00PM	David Hung's Nuvation to cut 30 jobs, end cancer drug program (American City Business Journals) -9.78% -8.03%
09:52AM	After FDA Hold, Nuvation Bio Stops NUV-422 Cancer Development Program (Benzinga)
08:00AM	Nuvation Bio Announces Discontinuation of NUV-422 Clinical Development Program (Business Wire)
Jul-27-22 12:00PM	Nuvation Bio Inc. (NUVB) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Jul-18-22 07:00AM	Nuvation Bio Appoints David Liu, M.D., Ph.D., as Chief Medical Officer and Kerry Wentworth as Chief Regulatory Officer (Business Wire)
Jun-27-22 08:52AM	FDA Institutes Partial Hold On Nuvation Bio's Early-Stage Solid Tumor Trial - Read Why (Benzinga) -13.13%
07:00AM	Nuvation Bio Announces FDA Partial Clinical Hold for Phase 1 Study of NUV-422 in Solid Tumors (Business Wire)
May-23-22 11:36AM	Legendary Value Investor Seth Klarman is Buying These 10 Stocks (Insider Monkey) -8.70%
May-09-22 04:05PM	Nuvation Bio Reports First Quarter 2022 Financial Results and Provides Business Update (Business Wire) -6.21%
Feb-28-22 04:05PM	Nuvation Bio Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update (Business Wire) -5.07%
Jan-21-22 10:21AM	Nuvation (NUVB) Gets FDA Clearance for Oncology Candidate (Zacks)
Jan-20-22 08:43AM	FDA clears Nuvation Bio's IND Application For NUV-868 In Advanced Solid Tumors (Benzinga)
07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-868 for the Treatment of Advanced Solid Tumors (PR Newswire)
Jan-14-22 12:31PM	Where Do Hedge Funds Stand On Nuvation Bio Inc. (NUVB)? (Insider Monkey)
Jan-10-22 07:00AM	Nuvation Bio Provides Corporate Update and Highlights Key 2022 Milestones (PR Newswire)
Dec-17-21 08:00AM	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies (PR Newswire) -8.74%
Dec-15-21 07:00AM	Nuvation Bio Receives FDA Fast Track Designation for NUV-422 for the Treatment of High-Grade Gliomas, Including Glioblastoma Multiforme (PR Newswire)
Dec-13-21 10:33AM	Billionaire Israel Englander Snaps Up These 3 Strong Buy Stocks (TipRanks) +8.98%
07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer (PR Newswire)
Dec-08-21 07:00AM	Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Advanced Breast Cancer (PR Newswire)
Nov-19-21 08:24AM	Is Nuvation Bio Inc. (NYSE:NUVB) Popular Amongst Insiders? (Simply Wall St.)
Nov-10-21 04:05PM	Nuvation Bio Reports Third Quarter 2021 Financial Results and Provides Business Update (PR Newswire)
Oct-25-21 09:12AM	Is Nuvation Bio Inc. (NUVB) A Good Stock To Buy? (Insider Monkey) +6.52%
Sep-20-21 04:14PM	15 Best Stocks to Invest in Today According to David Abrams (Insider Monkey)
Aug-12-21 04:05PM	Nuvation Bio Reports Second Quarter 2021 Financial Results and Provides Business Update (PR Newswire) +5.35%
Jul-06-21 10:20AM	Should I Buy Nuvation Bio Inc. (NUVB)? (Insider Monkey)
Jun-01-21 07:00AM	Nuvation Bio Appoints David C. Hanley, Ph.D., as Chief Technical Operations Officer (PR Newswire)
May-26-21 07:00AM	Nuvation Bio to Participate in the Jefferies Virtual Healthcare Conference (PR Newswire)
May-21-21 04:34PM	David Abrams Buys 3 Stocks in 1st Quarter (GuruFocus.com)
May-17-21 05:00PM	Nuvation Bio Reports First Quarter 2021 Financial Results and Provides Business Update (PR Newswire) +8.08%
May-11-21 05:51AM	How Much Of Nuvation Bio Inc. (NYSE:NUVB) Do Insiders Own? (Simply Wall St.)
Apr-17-21 09:36PM	Top Insider Buys Highlight for the Week of April 16 (GuruFocus.com)
Mar-11-21 05:15PM	Nuvation Bio Reports Full Year 2020 Financial Results and Provides Business Update (PR Newswire) +7.28%
07:00AM	Nuvation Bio Granted Orphan Drug Designation for NUV-422 for the Treatment of Patients with Malignant Gliomas (PR Newswire)

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wang Junyuan Jerry	CEO, ANHEART THERAPEUTICS LTD.	Nov 11 '24	Sale	2.89	56,361	162,883	3,866,228	Nov 13 04:28 PM
Mashal Robert	Director	Oct 08 '24	Buy	2.20	100,000	220,000	100,000	Oct 10 04:33 PM
Cui Xiangmin	Director	Jun 25 '24	Buy	2.97	277,895	825,348	2,453,131	Jun 26 04:31 PM
Cui Xiangmin	Director	Jun 24 '24	Buy	2.98	336,874	1,003,885	2,175,236	Jun 25 05:45 PM
Cui Xiangmin	Director	Jun 20 '24	Buy	2.99	87,715	262,268	1,762,951	Jun 25 05:45 PM
Cui Xiangmin	Director	Jun 21 '24	Buy	3.00	75,411	226,233	1,838,362	Jun 25 05:45 PM
BLICKENSTAFF KIM D	Director	Jun 11 '24	Buy	2.90	172,189	500,089	172,189	Jun 13 04:33 PM
WELCH DANIEL G	Director	May 24 '24	Option Exercise	1.68	659,947	1,111,633	659,947	May 29 04:38 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NUVB

Nuvation Bio Inc

Upgrade your FINVIZ experience